• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    COMPASS Pathways Plc - American Depository Shares (NQ: CMPS )

    4.990 +0.260 (+5.50%)
    Streaming Delayed Price Updated: 9:45 AM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about COMPASS Pathways Plc - American Depository Shares

    < Previous 1 2
    ...
    10 11 12 13 14 15 16 17 18
    ...
    28 29 Next >
    Psychedelic Stock Gainers And Losers From November 23, 2022
    Via Benzinga
    Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue
    (Part three of a four-part series) Have a look at previous stories: 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From November 22, 2022
    Via Benzinga
    Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
    Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From November 21, 2022
    Via Benzinga
    Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS' Latest Trial Outcomes
    (Part one of a four-part series) 
    Via Benzinga
    COMPASS Pathways plc (CMPS) Q3 2022 Earnings Call Transcript
    CMPS earnings call for the period ending September 30, 2022. 
    Via The Motley Fool
    Compass Pathways: Q3 Earnings Insights
    Compass Pathways (NASDAQ:CMPS) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Psychedelic Drug Stocks Index Continued To Decline Last Week
    This article highlights the performances of the 6 constituents in the munKNEE Psychedelic Drug Stocks Index last week and in the last 3 weeks and the extent to which each company is likely to encounter... 
    Via Talk Markets
    Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
    Via Benzinga
    Psychedelics And Treatment-Resistant Depression: Reactions To COMPASS' Published Results
    (Part two of a four-part series) See previous story in this series: Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS’ Latest Trial Outcomes 
    Via Benzinga
    Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
    Via Benzinga
    Psychedelic Stock Gainers And Losers From November 16, 2022
    Via Benzinga
    GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
    Via Benzinga
    Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8%
    We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic... 
    Via Talk Markets
    A Comparison Of 5 Psychedelic ETFs And Indices
    A look at 2 psychedelic ETFs and 3 tracking (non-trading) indices in the sector. 
    Via Talk Markets
    Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
    GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05 
    Via Benzinga
    Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
    GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS: 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From November 8, 2022
    GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14 
    Via Benzinga
    The Psychedelic Drug Stocks Index Continued To Plummet Last Week
    In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD. 
    Via Talk Markets
    Compass Pathways, Allied Among Top Psychedelic Movers Of Today
    GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44 
    Via Benzinga
    EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance
    (Part four of a four-part series) See previous stories in this series:  
    Via Benzinga
    COMPASS Pathways Shares Q3 2022 Financial Results, Business News & Term's Highlights
    Psychedelics mental healthcare firm COMPASS Pathways (NASDAQ: CMPS) reported its financial outcomes for the third quarter ended 30 September 2022 and gave an update on its most recent pipeline and... 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From November 3, 2022
    GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27 
    Via Benzinga
    Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S.
    Easily identified by its red cap covered with white dots and a white stem, the Amanita muscaria mushroom is probably the most famous and easily recognizable mushroom in the world. Popularized by Lewis... 
    Via Benzinga
    COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights
    From COMPASS Pathways
    Via GlobeNewswire
    Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
    GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS: 
    Via Benzinga
    Compass Pathways's Earnings Outlook
    Compass Pathways (NASDAQ:CMPS) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Compass... 
    Via Benzinga
    Why Shares of atai Life Sciences Climbed 14.58% on Tuesday
    The company specializes in developing psychedelics as therapies. 
    Via The Motley Fool
    Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
    Upgrades 
    Via Benzinga
    < Previous 1 2
    ...
    10 11 12 13 14 15 16 17 18
    ...
    28 29 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.